Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: unbiased (1), impartial (11), pale (37)

HSCTCyclophosphamide Priming (1500)

Description: Chemotherapy Protocol Haematopoietic Stem Cell Transplant (Autograft) CYCLOPHOSPHAMIDE PRIMING (1500mg/m2) Regimen • Haematopoietic Stem Cell Transplant (HSCT)- Cyclophospha
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTCyclophosphamide-Priming-1500.pdf

MP000 028 Cellular pathology user handbook v24

Description: University Hospital Southampton NHS Foundation Trust PATHOLOGY DIRECTORATE Cellular Pathology (Management) MP 000 028 Revision 24 Page 1 of 24 Cellular Patholo
Url: /Media/UHS-website-2019/Docs/Services/Pathology/Cell-path/MP000-028-Cellular-pathology-user-handbook-v24.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epirubicin-Etoposide-Ifosfamide Indication • Non Hodgkin’s Lymphoma • Hodgkin’s
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Etoposide-Ifosfamide (VIP) Indication • Metastatic Germ Cel
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require funding Regimen • Ovary-Bevacizumab (15)-Carboplatin (AUC4
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

UHS ISH and IHC request form

Description: Lab use: Barcode Cellular Pathology UKAS reference: 8178 Date: Specimen(s) received: UHS IHC and ISH Request Form Referrer Information Referring clin
Url: /Media/UHS-website-2019/Docs/Services/Pathology/Cell-path/UHS-ISH-and-IHC-request-form.pdf

ClofarabineCytarabine

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA ALL CLOFARABINE-CYTARABINE In-Patient Regimen Clofarabine not licensed in adult patients. This may require funding Regimen • Acut
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/ClofarabineCytarabine.pdf

InP-Cisplatin-Ifosfamide-Paclitaxel (TIP) Ver1.2

Description: Chemotherapy Protocol GERM CELL CISPLATIN-IFOSFAMIDE-PACLITAXEL (TIP) Inpatient Regimen Regimen Germ Cell – InP-Cisplatin-Ifosfamide-Paclitaxel (TIP) Indication Relapsed Metasta
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Ifosfamide-Paclitaxel-TIP-Ver1.2.pdf

FC IV (3 day)-Cyclophosphamide-Fludarabine IV (3 day) Ver 1.1

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE–FLUDARABINE INTRAVENOUS (FC IV 3 day) Regimen Lymphoma – FC IV (3 day)- Cyclophosphamide-Fludarabine IV (3 day) In
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/FC-IV-3-day-Cyclophosphamide-Fludarabine-IV-3-day-Ver-1.1.pdf

InP Doxorubicin Etoposide Ifosfamide Vincristine VIDEVer1

Description: Chemotherapy Protocol SARCOMA DOXORUBICIN-ETOPOSIDE-IFOSFAMIDE -VINCRISTINE (VIDE) Inpatient Regimen Regimen Sarcoma-InP- Doxorubicin-Etoposide-Ifosfamide-Vincristine (VIDE) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinEtoposideIfosfamideVincristineVIDEVer1.pdf

21 to 30 of 265

Previous 1 2 3 4 5 … Next